Loading...
Loading...
Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at United Therapeutics
UTHR is 30.05%. United Therapeutics' revenue for the same period is $1.01 billion.
The trailing-twelve-month profit margin at Warner Chilcott plc
WCRX is 18.89%. Warner Chilcott's operating margin for the same period is 32.10%.
The trailing-twelve-month profit margin at Dr. Reddy's Laboratories
RDY is 14.36%. Dr. Reddy's ROE for the same period is 25.28%.
The trailing-twelve-month profit margin at Cubist Pharmaceuticals
CBST is 10.23%. Cubist Pharmaceuticals' PEG ratio is 2.13.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in